
A study of 21,341 Australians aged 45+ found high initial adherence to glucose-lowering drugs, with some decline in year two. Long-term users of GLP-1 and SGLT2 inhibitors showed increased adherence over time. No socio-demographic group was consistently more or less adherent. Experts urge doctors to monitor for possible non-adherence.
Like
Save
Share